Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT06366347 |
Title | ALPINE: Maintenance Letrozole/Abemaciclib vs Pembrolizumab |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Dana-Farber Cancer Institute |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Beth Israel Deaconess Medical Center | NOT_YET_RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
Brigham and Women's Hospital | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
Dana-Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
Dana-Farber Cancer Institute at Foxborough | RECRUITING | Foxboro | Massachusetts | 02035 | United States | Details |
Dana-Farber Cancer Institute at Milford | RECRUITING | Milford | Massachusetts | 01757 | United States | Details |
Dana-Farber Cancer Institute at South Shore Hospital | RECRUITING | Weymouth | Massachusetts | 02190 | United States | Details |